LYFRISTO Trademark

Trademark Overview


On Thursday, June 29, 2017, a trademark application was filed for LYFRISTO with the United States Patent and Trademark Office. The USPTO has given the LYFRISTO trademark a serial number of 87511079. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 22, 2025. This trademark is owned by Abiogen Pharma S.p.A.. The LYFRISTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronate sodium; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronate sodium
lyfristo

General Information


Serial Number87511079
Word MarkLYFRISTO
Filing DateThursday, June 29, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 22, 2025
Registration Number5672248
Registration DateTuesday, February 12, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronic acid and/or its salts thereof; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies containing neridronate sodium; pharmaceutical preparations for the treatment of pain, bone metabolic pathologies and osteo-articular pathologies, namely, neridronate sodium

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 22, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbiogen Pharma S.p.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressOspedaletto, Pisa (PI) 56121
IT

Party NameAbiogen Pharma S.p.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressOspedaletto, Pisa (PI) 56121
IT

Party NameAbiogen Pharma S.p.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOspedaletto, Pisa (PI) 56121
IT

Trademark Events


Event DateEvent Description
Saturday, July 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2017ASSIGNED TO EXAMINER
Monday, October 9, 2017SUSPENSION LETTER WRITTEN
Monday, October 9, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 9, 2017LETTER OF SUSPENSION E-MAILED
Monday, April 9, 2018SUSPENSION INQUIRY WRITTEN
Monday, April 9, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 9, 2018INQUIRY TO SUSPENSION E-MAILED
Monday, October 8, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 8, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 17, 2018ASSIGNED TO LIE
Tuesday, October 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 27, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019REGISTERED-PRINCIPAL REGISTER
Monday, February 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 22, 2025CANCELLED SEC. 8 (6-YR)
Tuesday, October 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 3, 2017NEW APPLICATION ENTERED
Tuesday, October 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE